Jessica Chew, MD

Jessica Chew

Educational Background

Radiation Oncology Residency, University of California San Francisco (2018-2022)

Preliminary Medicine Internship, Alameda County Medical Center-Highland Hospital (2018)

M.D., Georgetown University School of Medicine (2017)

B.S., Biophysics, University of California Los Angeles (2012)

Awards & Honors

Cum Laude (2012)

Dean's Honor List (2008-2012)

Selected Publications, Abstracts and Posters

Kataria S, Chew J, Lei S, Ayoob MJ, Danner M, Yung T, Collins BT, Suy S, Dritschilo A, Lynch JH, Collins SP. Stereotactic body radiation therapy (SBRT) for prostate cancer in men with high international prostate symptom score (IPSS; 15). Int J Radiat Oncol Biol Phys. 2017 Oct;99(2S): E538-9.

Shaikh F, Chew J, Perez CA, Tam M, Cooper BT, Maisonet OG, Peat E, Huppert NE, Formenti SC, Gerber NK. Hypofractionated whole breast irradiation in women less than 50 years old treated on prospective protocols: a report on long-term cosmesis. Int J Radiat Oncol Biol Phys. 2017 Oct; 99(2S): S7.

Lischalk JW, Burke A, Chew J, Elledge C, Gurka M, Marshall J, Pishvaian M, Collins S, Unger K. Five-fraction stereotactic body radiation therapy (SBRT) and chemotherapy for the local management of metastatic pancreatic cancer. J Gastrointest Cancer. 2017 Jan; doi:10.1007/s12029-016-9909-2.

Parker E, Durcanova B, Diaz-Aguilar D, Torosyan N, Chew J, Dahlbom M, Czernin J, Phelps M, Silverman D. Projected value of amyloid imaging in improving long-term clinical outcomes in MCI patients with prognostically ambiguous FDG-PET. J Nucl Med. 2015 May; 56(Supplement 3):191.

Ahn R, Ganz P, Chew J, Kwan L, Castellon S, Irwin M, Silverman D. Endocrine therapy is associated with increased visuomotor performance and occipital cerebral metabolism in prospectively studied breast cancer patients. Accepted for presentation at the International Cognition and Cancer Task Force Conference, Seattle, Washington, February 2014.

Chew J, Pomykala K, Lu P, Foster N, Hoffman J, Dennett K, Zamrini E, Czernin J, Phelps M, Silverman D. Obtaining brain PET data is associated with more AD-specific drug prescription and improved clinical outcomes for subjects with cerebrometabolic evidence of AD. J Nucl Med. 2013 May; 54(Supplement 2):1804.

Chew J, Silverman D. FDG-PET in early AD diagnosis. M Clin North Am. 2013 May; 97(3):485-94.

Chew J, Geist C, Pomykala K, Lu P, Foster N, Hoffman J, Dennett K, Czernin J, Silverman D, Phelps M. Prescription of Alzheimer-specific drugs and long-term preservation of language function are positively associated with early release of regional cerebral metabolic data in a multi-center prospective randomized trial. Alzheimers Dement. 2012 July; 8(4):P631-P632.

Chew J, Geist C, Pomykala K, Foster N, Hoffman J, Dennett K, Zamrini E, Czernin J, Phelps M, Silverman D. Prescription pattern of Alzheimer-specific drugs is positively associated with immediate release of brain PET scan data in the Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID) trial. J Nucl Med. 2012 May; 53(Supplement 1):1958.